Pin1-Catalyzed Conformation Changes Regulate Protein Ubiquitination and Degradation

Jeong,Usman,Li,Zhou,Lu

DOI: https://doi.org/10.3390/cells13090731

IF: 6

2024-04-24

Cells

Abstract:The unique prolyl isomerase Pin1 binds to and catalyzes cis–trans conformational changes of specific Ser/Thr-Pro motifs after phosphorylation, thereby playing a pivotal role in regulating the structure and function of its protein substrates. In particular, Pin1 activity regulates the affinity of a substrate for E3 ubiquitin ligases, thereby modulating the turnover of a subset of proteins and coordinating their activities after phosphorylation in both physiological and disease states. In this review, we highlight recent advancements in Pin1-regulated ubiquitination in the context of cancer and neurodegenerative disease. Specifically, Pin1 promotes cancer progression by increasing the stabilities of numerous oncoproteins and decreasing the stabilities of many tumor suppressors. Meanwhile, Pin1 plays a critical role in different neurodegenerative disorders via the regulation of protein turnover. Finally, we propose a novel therapeutic approach wherein the ubiquitin–proteasome system can be leveraged for therapy by targeting pathogenic intracellular targets for TRIM21-dependent degradation using stereospecific antibodies.

cell biology

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore how Pin1 (a unique prolyl isomerase) regulates the ubiquitination and degradation processes of proteins by catalyzing the cis - trans conformational changes of specific phosphorylated Ser/Thr - Pro motifs. Specifically, the activity of Pin1 can regulate the affinity between substrates and E3 ubiquitin ligases, thereby affecting protein stability and the coordination of their activities in physiological and disease states. The paper pays special attention to the role of Pin1 in cancer and neurodegenerative diseases, including how it promotes cancer progression by increasing the stability of multiple oncoproteins and reducing the stability of many tumor suppressors, and at the same time plays a crucial role in different neurodegenerative diseases by regulating protein turnover. Finally, the paper proposes a novel therapeutic strategy, that is, to manipulate the ubiquitin - proteasome system for treatment by using TRIM21 - dependent degradation targeting pathological intracellular targets.